General Information of Target

Target ID LDTP06547
Target Name Mitogen-activated protein kinase 14 (MAPK14)
Gene Name MAPK14
Gene ID 1432
Synonyms
CSBP; CSBP1; CSBP2; CSPB1; MXI2; SAPK2A; Mitogen-activated protein kinase 14; MAP kinase 14; MAPK 14; EC 2.7.11.24; Cytokine suppressive anti-inflammatory drug-binding protein; CSAID-binding protein; CSBP; MAP kinase MXI2; MAX-interacting protein 2; Mitogen-activated protein kinase p38 alpha; MAP kinase p38 alpha; Stress-activated protein kinase 2a; SAPK2a
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Sequence
MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ
SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ
KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT
GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG
TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA
QALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES
Target Type
Clinical trial
Target Bioclass
Enzyme
Family
Protein kinase superfamily, CMGC Ser/Thr protein kinase family, MAP kinase subfamily
Subcellular location
Cytoplasm
Function
Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. MAPK14 is one of the four p38 MAPKs which play an important role in the cascades of cellular responses evoked by extracellular stimuli such as pro-inflammatory cytokines or physical stress leading to direct activation of transcription factors. Accordingly, p38 MAPKs phosphorylate a broad range of proteins and it has been estimated that they may have approximately 200 to 300 substrates each. Some of the targets are downstream kinases which are activated through phosphorylation and further phosphorylate additional targets. RPS6KA5/MSK1 and RPS6KA4/MSK2 can directly phosphorylate and activate transcription factors such as CREB1, ATF1, the NF-kappa-B isoform RELA/NFKB3, STAT1 and STAT3, but can also phosphorylate histone H3 and the nucleosomal protein HMGN1. RPS6KA5/MSK1 and RPS6KA4/MSK2 play important roles in the rapid induction of immediate-early genes in response to stress or mitogenic stimuli, either by inducing chromatin remodeling or by recruiting the transcription machinery. On the other hand, two other kinase targets, MAPKAPK2/MK2 and MAPKAPK3/MK3, participate in the control of gene expression mostly at the post-transcriptional level, by phosphorylating ZFP36 (tristetraprolin) and ELAVL1, and by regulating EEF2K, which is important for the elongation of mRNA during translation. MKNK1/MNK1 and MKNK2/MNK2, two other kinases activated by p38 MAPKs, regulate protein synthesis by phosphorylating the initiation factor EIF4E2. MAPK14 interacts also with casein kinase II, leading to its activation through autophosphorylation and further phosphorylation of TP53/p53. In the cytoplasm, the p38 MAPK pathway is an important regulator of protein turnover. For example, CFLAR is an inhibitor of TNF-induced apoptosis whose proteasome-mediated degradation is regulated by p38 MAPK phosphorylation. In a similar way, MAPK14 phosphorylates the ubiquitin ligase SIAH2, regulating its activity towards EGLN3. MAPK14 may also inhibit the lysosomal degradation pathway of autophagy by interfering with the intracellular trafficking of the transmembrane protein ATG9. Another function of MAPK14 is to regulate the endocytosis of membrane receptors by different mechanisms that impinge on the small GTPase RAB5A. In addition, clathrin-mediated EGFR internalization induced by inflammatory cytokines and UV irradiation depends on MAPK14-mediated phosphorylation of EGFR itself as well as of RAB5A effectors. Ectodomain shedding of transmembrane proteins is regulated by p38 MAPKs as well. In response to inflammatory stimuli, p38 MAPKs phosphorylate the membrane-associated metalloprotease ADAM17. Such phosphorylation is required for ADAM17-mediated ectodomain shedding of TGF-alpha family ligands, which results in the activation of EGFR signaling and cell proliferation. Another p38 MAPK substrate is FGFR1. FGFR1 can be translocated from the extracellular space into the cytosol and nucleus of target cells, and regulates processes such as rRNA synthesis and cell growth. FGFR1 translocation requires p38 MAPK activation. In the nucleus, many transcription factors are phosphorylated and activated by p38 MAPKs in response to different stimuli. Classical examples include ATF1, ATF2, ATF6, ELK1, PTPRH, DDIT3, TP53/p53 and MEF2C and MEF2A. The p38 MAPKs are emerging as important modulators of gene expression by regulating chromatin modifiers and remodelers. The promoters of several genes involved in the inflammatory response, such as IL6, IL8 and IL12B, display a p38 MAPK-dependent enrichment of histone H3 phosphorylation on 'Ser-10' (H3S10ph) in LPS-stimulated myeloid cells. This phosphorylation enhances the accessibility of the cryptic NF-kappa-B-binding sites marking promoters for increased NF-kappa-B recruitment. Phosphorylates CDC25B and CDC25C which is required for binding to 14-3-3 proteins and leads to initiation of a G2 delay after ultraviolet radiation. Phosphorylates TIAR following DNA damage, releasing TIAR from GADD45A mRNA and preventing mRNA degradation. The p38 MAPKs may also have kinase-independent roles, which are thought to be due to the binding to targets in the absence of phosphorylation. Protein O-Glc-N-acylation catalyzed by the OGT is regulated by MAPK14, and, although OGT does not seem to be phosphorylated by MAPK14, their interaction increases upon MAPK14 activation induced by glucose deprivation. This interaction may regulate OGT activity by recruiting it to specific targets such as neurofilament H, stimulating its O-Glc-N-acylation. Required in mid-fetal development for the growth of embryo-derived blood vessels in the labyrinth layer of the placenta. Also plays an essential role in developmental and stress-induced erythropoiesis, through regulation of EPO gene expression. Isoform MXI2 activation is stimulated by mitogens and oxidative stress and only poorly phosphorylates ELK1 and ATF2. Isoform EXIP may play a role in the early onset of apoptosis. Phosphorylates S100A9 at 'Thr-113'. Phosphorylates NLRP1 downstream of MAP3K20/ZAK in response to UV-B irradiation and ribosome collisions, promoting activation of the NLRP1 inflammasome and pyroptosis.; (Microbial infection) Activated by phosphorylation by M.tuberculosis EsxA in T-cells leading to inhibition of IFN-gamma production; phosphorylation is apparent within 15 minutes and is inhibited by kinase-specific inhibitors SB203580 and siRNA.
TTD ID
T65864
Uniprot ID
Q16539
DrugMap ID
TTQBR95
Ensemble ID
ENST00000229794.9
HGNC ID
HGNC:6876
ChEMBL ID
CHEMBL260

Target Site Mutations in Different Cell Lines

Cell line Mutation details Probe for labeling this protein in this cell
HT115 SNV: p.K121T; p.R296I .
IGROV1 SNV: p.L164P .
P31FUJ SNV: p.I146T DBIA    Probe Info 
SNU1 SNV: p.E253A; p.L289F DBIA    Probe Info 

Probe(s) Labeling This Target

ABPP Probe
Click To Hide/Show 22 Probe Related to This Target
Probe name Structure Binding Site(Ratio) Interaction ID Ref
TH211
 Probe Info 
Y182(20.00); Y35(13.99)  LDD0257  [1]
TH214
 Probe Info 
Y182(20.00)  LDD0258  [1]
TH216
 Probe Info 
Y182(20.00)  LDD0259  [1]
STPyne
 Probe Info 
K165(2.06); K295(1.75)  LDD0277  [2]
m-APA
 Probe Info 
13.62  LDD0403  [3]
Dasatinib-CA-4PAP
 Probe Info 
17.07  LDD0270  [4]
BTD
 Probe Info 
C162(0.61)  LDD2095  [5]
AHL-Pu-1
 Probe Info 
C162(2.46)  LDD0168  [6]
HHS-465
 Probe Info 
Y182(10.00)  LDD2237  [7]
DBIA
 Probe Info 
C39(1.54)  LDD0531  [8]
ATP probe
 Probe Info 
N.A.  LDD0199  [9]
4-Iodoacetamidophenylacetylene
 Probe Info 
C162(0.00); C39(0.00)  LDD0038  [10]
IA-alkyne
 Probe Info 
C162(0.00); C39(0.00)  LDD0036  [10]
Lodoacetamide azide
 Probe Info 
C162(0.00); C39(0.00)  LDD0037  [10]
JW-RF-010
 Probe Info 
C39(0.00); C162(0.00)  LDD0026  [11]
TFBX
 Probe Info 
N.A.  LDD0027  [11]
Compound 10
 Probe Info 
N.A.  LDD2216  [12]
IPM
 Probe Info 
N.A.  LDD2156  [13]
1c-yne
 Probe Info 
N.A.  LDD0228  [14]
Acrolein
 Probe Info 
N.A.  LDD0217  [15]
AOyne
 Probe Info 
11.30  LDD0443  [16]
NAIA_5
 Probe Info 
C162(0.00); C119(0.00); C39(0.00)  LDD2223  [17]
PAL-AfBPP Probe
Click To Hide/Show 6 Probe Related to This Target
Probe name Structure Binding Site(Ratio) Interaction ID Ref
C158
 Probe Info 
9.51  LDD1838  [18]
C275
 Probe Info 
4.92  LDD1945  [18]
C282
 Probe Info 
23.10  LDD1952  [18]
Dasatinib-CA-3PAP
 Probe Info 
N.A.  LDD0365  [4]
Dasatinib-CA-8PAP
 Probe Info 
5.02; 0.00  LDD0364  [4]
DA-2
 Probe Info 
N.A.  LDD0070  [19]

Competitor(s) Related to This Target

Competitor ID Name Cell line Binding Site(Ratio) Interaction ID Ref
 LDCM0502  1-(Cyanoacetyl)piperidine MDA-MB-231 C162(0.61)  LDD2095  [5]
 LDCM0537  2-Cyano-N,N-dimethylacetamide MDA-MB-231 C162(1.05)  LDD2130  [5]
 LDCM0539  3-(4-Isopropylpiperazin-1-yl)-3-oxopropanenitrile MDA-MB-231 C162(0.69)  LDD2132  [5]
 LDCM0025  4SU-RNA HEK-293T C162(2.46)  LDD0168  [6]
 LDCM0214  AC1 HCT 116 C39(1.54)  LDD0531  [8]
 LDCM0215  AC10 PaTu 8988t C39(0.30)  LDD1094  [8]
 LDCM0216  AC100 HCT 116 C39(0.38)  LDD0533  [8]
 LDCM0217  AC101 HCT 116 C39(0.43)  LDD0534  [8]
 LDCM0218  AC102 HCT 116 C39(0.56)  LDD0535  [8]
 LDCM0219  AC103 HCT 116 C39(0.34)  LDD0536  [8]
 LDCM0220  AC104 HCT 116 C39(0.68)  LDD0537  [8]
 LDCM0221  AC105 HCT 116 C39(0.41)  LDD0538  [8]
 LDCM0222  AC106 HCT 116 C39(0.35)  LDD0539  [8]
 LDCM0223  AC107 HCT 116 C39(0.41)  LDD0540  [8]
 LDCM0224  AC108 HCT 116 C39(0.35)  LDD0541  [8]
 LDCM0225  AC109 HCT 116 C39(0.84)  LDD0542  [8]
 LDCM0226  AC11 PaTu 8988t C39(0.32)  LDD1105  [8]
 LDCM0227  AC110 HCT 116 C39(0.34)  LDD0544  [8]
 LDCM0228  AC111 HCT 116 C39(0.33)  LDD0545  [8]
 LDCM0229  AC112 HCT 116 C39(0.32)  LDD0546  [8]
 LDCM0230  AC113 HCT 116 C162(0.74); C39(0.94)  LDD0547  [8]
 LDCM0231  AC114 HCT 116 C162(0.80); C39(0.84)  LDD0548  [8]
 LDCM0232  AC115 HCT 116 C162(0.71); C39(0.65)  LDD0549  [8]
 LDCM0233  AC116 HCT 116 C162(0.93); C39(0.95)  LDD0550  [8]
 LDCM0234  AC117 HCT 116 C162(0.85); C39(0.94)  LDD0551  [8]
 LDCM0235  AC118 HCT 116 C162(0.76); C39(1.08)  LDD0552  [8]
 LDCM0236  AC119 HCT 116 C162(0.71); C39(1.08)  LDD0553  [8]
 LDCM0237  AC12 PaTu 8988t C39(0.32)  LDD1116  [8]
 LDCM0238  AC120 HCT 116 C162(0.79); C39(0.87)  LDD0555  [8]
 LDCM0239  AC121 HCT 116 C162(0.72); C39(1.50)  LDD0556  [8]
 LDCM0240  AC122 HCT 116 C162(0.86); C39(1.05)  LDD0557  [8]
 LDCM0241  AC123 HCT 116 C162(0.70); C39(1.31)  LDD0558  [8]
 LDCM0242  AC124 HCT 116 C162(0.45); C39(1.39)  LDD0559  [8]
 LDCM0243  AC125 HCT 116 C162(0.87); C39(1.48)  LDD0560  [8]
 LDCM0244  AC126 HCT 116 C162(0.56); C39(1.41)  LDD0561  [8]
 LDCM0245  AC127 HCT 116 C162(0.57); C39(1.45)  LDD0562  [8]
 LDCM0246  AC128 HCT 116 C39(0.28)  LDD0563  [8]
 LDCM0247  AC129 HCT 116 C39(1.20)  LDD0564  [8]
 LDCM0249  AC130 HCT 116 C39(0.50)  LDD0566  [8]
 LDCM0250  AC131 HCT 116 C39(1.36)  LDD0567  [8]
 LDCM0251  AC132 HCT 116 C39(1.32)  LDD0568  [8]
 LDCM0252  AC133 HCT 116 C39(0.56)  LDD0569  [8]
 LDCM0253  AC134 HCT 116 C39(0.59)  LDD0570  [8]
 LDCM0254  AC135 HCT 116 C39(0.51)  LDD0571  [8]
 LDCM0255  AC136 HCT 116 C39(0.78)  LDD0572  [8]
 LDCM0256  AC137 HCT 116 C39(1.15)  LDD0573  [8]
 LDCM0257  AC138 HCT 116 C39(0.67)  LDD0574  [8]
 LDCM0258  AC139 HCT 116 C39(0.84)  LDD0575  [8]
 LDCM0259  AC14 PaTu 8988t C39(0.75)  LDD1138  [8]
 LDCM0260  AC140 HCT 116 C39(0.59)  LDD0577  [8]
 LDCM0261  AC141 HCT 116 C39(0.87)  LDD0578  [8]
 LDCM0262  AC142 HCT 116 C39(1.01)  LDD0579  [8]
 LDCM0263  AC143 HCT 116 C39(0.93)  LDD0580  [8]
 LDCM0264  AC144 HCT 116 C39(0.62)  LDD0581  [8]
 LDCM0265  AC145 HCT 116 C39(1.19)  LDD0582  [8]
 LDCM0266  AC146 HCT 116 C39(0.57)  LDD0583  [8]
 LDCM0267  AC147 HCT 116 C39(0.49)  LDD0584  [8]
 LDCM0268  AC148 HCT 116 C39(0.19)  LDD0585  [8]
 LDCM0269  AC149 HCT 116 C39(0.38)  LDD0586  [8]
 LDCM0270  AC15 PaTu 8988t C39(0.52)  LDD1149  [8]
 LDCM0271  AC150 HCT 116 C39(1.01)  LDD0588  [8]
 LDCM0272  AC151 HCT 116 C39(1.06)  LDD0589  [8]
 LDCM0273  AC152 HCT 116 C39(0.37)  LDD0590  [8]
 LDCM0274  AC153 HCT 116 C39(0.19)  LDD0591  [8]
 LDCM0621  AC154 HCT 116 C39(0.63)  LDD2158  [8]
 LDCM0622  AC155 HCT 116 C39(0.76)  LDD2159  [8]
 LDCM0623  AC156 HCT 116 C39(1.43)  LDD2160  [8]
 LDCM0624  AC157 HCT 116 C39(1.19)  LDD2161  [8]
 LDCM0276  AC17 HCT 116 C39(1.05); C162(1.18)  LDD0593  [8]
 LDCM0277  AC18 HCT 116 C39(0.39); C162(1.19)  LDD0594  [8]
 LDCM0278  AC19 HCT 116 C39(0.83); C162(1.28)  LDD0595  [8]
 LDCM0279  AC2 HCT 116 C39(1.09)  LDD0596  [8]
 LDCM0280  AC20 HCT 116 C39(1.02); C162(1.04)  LDD0597  [8]
 LDCM0281  AC21 HCT 116 C39(0.83); C162(1.06)  LDD0598  [8]
 LDCM0282  AC22 HCT 116 C162(1.09); C39(1.29)  LDD0599  [8]
 LDCM0283  AC23 HCT 116 C162(0.87); C39(1.01)  LDD0600  [8]
 LDCM0284  AC24 HCT 116 C162(1.04); C39(1.27)  LDD0601  [8]
 LDCM0285  AC25 HCT 116 C162(1.17); C39(1.31)  LDD0602  [8]
 LDCM0286  AC26 HCT 116 C39(0.73); C162(1.35)  LDD0603  [8]
 LDCM0287  AC27 HCT 116 C39(0.76); C162(1.28)  LDD0604  [8]
 LDCM0288  AC28 HCT 116 C39(0.72); C162(1.50)  LDD0605  [8]
 LDCM0289  AC29 HCT 116 C39(0.49); C162(1.01)  LDD0606  [8]
 LDCM0290  AC3 HCT 116 C39(1.21)  LDD0607  [8]
 LDCM0291  AC30 HCT 116 C39(0.50); C162(1.07)  LDD0608  [8]
 LDCM0292  AC31 HCT 116 C39(0.60); C162(1.37)  LDD0609  [8]
 LDCM0293  AC32 HCT 116 C39(0.47); C162(1.19)  LDD0610  [8]
 LDCM0294  AC33 HCT 116 C162(0.84); C39(0.90)  LDD0611  [8]
 LDCM0295  AC34 HCT 116 C162(0.48); C39(0.79)  LDD0612  [8]
 LDCM0296  AC35 HCT 116 C162(1.12); C39(1.35)  LDD0613  [8]
 LDCM0297  AC36 HCT 116 C39(0.91); C162(1.00)  LDD0614  [8]
 LDCM0298  AC37 HCT 116 C162(0.98); C39(1.55)  LDD0615  [8]
 LDCM0299  AC38 HCT 116 C162(0.96); C39(0.98)  LDD0616  [8]
 LDCM0300  AC39 HCT 116 C162(0.66); C39(0.86)  LDD0617  [8]
 LDCM0301  AC4 HCT 116 C39(1.37)  LDD0618  [8]
 LDCM0302  AC40 HCT 116 C162(0.76); C39(0.96)  LDD0619  [8]
 LDCM0303  AC41 HCT 116 C39(1.05); C162(1.13)  LDD0620  [8]
 LDCM0304  AC42 HCT 116 C39(1.03); C162(1.11)  LDD0621  [8]
 LDCM0305  AC43 HCT 116 C39(0.89); C162(1.58)  LDD0622  [8]
 LDCM0306  AC44 HCT 116 C162(1.12); C39(1.86)  LDD0623  [8]
 LDCM0307  AC45 HCT 116 C162(1.13); C39(1.42)  LDD0624  [8]
 LDCM0308  AC46 HCT 116 C39(0.96)  LDD0625  [8]
 LDCM0309  AC47 HCT 116 C39(1.04)  LDD0626  [8]
 LDCM0310  AC48 HCT 116 C39(0.90)  LDD0627  [8]
 LDCM0311  AC49 HCT 116 C39(0.88)  LDD0628  [8]
 LDCM0312  AC5 HCT 116 C39(1.55)  LDD0629  [8]
 LDCM0313  AC50 HCT 116 C39(0.84)  LDD0630  [8]
 LDCM0314  AC51 HCT 116 C39(0.93)  LDD0631  [8]
 LDCM0315  AC52 HCT 116 C39(0.90)  LDD0632  [8]
 LDCM0316  AC53 HCT 116 C39(1.23)  LDD0633  [8]
 LDCM0317  AC54 HCT 116 C39(0.94)  LDD0634  [8]
 LDCM0318  AC55 HCT 116 C39(1.42)  LDD0635  [8]
 LDCM0319  AC56 HCT 116 C39(0.85)  LDD0636  [8]
 LDCM0320  AC57 HCT 116 C39(0.24); C162(1.01)  LDD0637  [8]
 LDCM0321  AC58 HCT 116 C39(0.18); C162(1.04)  LDD0638  [8]
 LDCM0322  AC59 HCT 116 C39(0.19); C162(1.07)  LDD0639  [8]
 LDCM0323  AC6 PaTu 8988t C39(0.50)  LDD1202  [8]
 LDCM0324  AC60 HCT 116 C39(0.18); C162(1.35)  LDD0641  [8]
 LDCM0325  AC61 HCT 116 C39(0.17); C162(1.01)  LDD0642  [8]
 LDCM0326  AC62 HCT 116 C39(0.14); C162(0.93)  LDD0643  [8]
 LDCM0327  AC63 HCT 116 C39(0.20); C162(1.03)  LDD0644  [8]
 LDCM0328  AC64 HCT 116 C39(0.14); C162(1.61)  LDD0645  [8]
 LDCM0329  AC65 HCT 116 C39(0.23); C162(1.39)  LDD0646  [8]
 LDCM0330  AC66 HCT 116 C39(0.22); C162(1.39)  LDD0647  [8]
 LDCM0331  AC67 HCT 116 C39(0.08); C162(0.94)  LDD0648  [8]
 LDCM0332  AC68 HCT 116 C39(0.65)  LDD0649  [8]
 LDCM0333  AC69 HCT 116 C39(0.55)  LDD0650  [8]
 LDCM0334  AC7 PaTu 8988t C39(1.10)  LDD1213  [8]
 LDCM0335  AC70 HCT 116 C39(0.40)  LDD0652  [8]
 LDCM0336  AC71 HCT 116 C39(0.82)  LDD0653  [8]
 LDCM0337  AC72 HCT 116 C39(0.60)  LDD0654  [8]
 LDCM0338  AC73 HCT 116 C39(0.35)  LDD0655  [8]
 LDCM0339  AC74 HCT 116 C39(0.45)  LDD0656  [8]
 LDCM0340  AC75 HCT 116 C39(0.41)  LDD0657  [8]
 LDCM0341  AC76 HCT 116 C39(0.59)  LDD0658  [8]
 LDCM0342  AC77 HCT 116 C39(0.52)  LDD0659  [8]
 LDCM0343  AC78 HCT 116 C39(0.65)  LDD0660  [8]
 LDCM0344  AC79 HCT 116 C39(0.66)  LDD0661  [8]
 LDCM0345  AC8 PaTu 8988t C39(0.76)  LDD1224  [8]
 LDCM0346  AC80 HCT 116 C39(0.70)  LDD0663  [8]
 LDCM0347  AC81 HCT 116 C39(0.79)  LDD0664  [8]
 LDCM0348  AC82 HCT 116 C39(0.44)  LDD0665  [8]
 LDCM0349  AC83 HCT 116 C39(0.40)  LDD0666  [8]
 LDCM0350  AC84 HCT 116 C39(0.44)  LDD0667  [8]
 LDCM0351  AC85 HCT 116 C39(0.65)  LDD0668  [8]
 LDCM0352  AC86 HCT 116 C39(0.83)  LDD0669  [8]
 LDCM0353  AC87 HCT 116 C39(0.98)  LDD0670  [8]
 LDCM0354  AC88 HCT 116 C39(0.96)  LDD0671  [8]
 LDCM0355  AC89 HCT 116 C39(0.65)  LDD0672  [8]
 LDCM0357  AC90 HCT 116 C39(2.73)  LDD0674  [8]
 LDCM0358  AC91 HCT 116 C39(0.44)  LDD0675  [8]
 LDCM0359  AC92 HCT 116 C39(0.43)  LDD0676  [8]
 LDCM0360  AC93 HCT 116 C39(0.93)  LDD0677  [8]
 LDCM0361  AC94 HCT 116 C39(0.80)  LDD0678  [8]
 LDCM0362  AC95 HCT 116 C39(0.62)  LDD0679  [8]
 LDCM0363  AC96 HCT 116 C39(0.64)  LDD0680  [8]
 LDCM0364  AC97 HCT 116 C39(0.46)  LDD0681  [8]
 LDCM0365  AC98 HCT 116 C39(0.32)  LDD0682  [8]
 LDCM0366  AC99 HCT 116 C39(0.43)  LDD0683  [8]
 LDCM0248  AKOS034007472 PaTu 8988t C39(0.33)  LDD1127  [8]
 LDCM0356  AKOS034007680 PaTu 8988t C39(0.28)  LDD1235  [8]
 LDCM0275  AKOS034007705 PaTu 8988t C39(0.29)  LDD1154  [8]
 LDCM0156  Aniline NCI-H1299 13.62  LDD0403  [3]
 LDCM0108  Chloroacetamide HeLa C162(0.00); C39(0.00)  LDD0222  [15]
 LDCM0367  CL1 HEK-293T C162(1.11)  LDD1571  [20]
 LDCM0368  CL10 HEK-293T C162(0.78); C39(1.12)  LDD1572  [20]
 LDCM0369  CL100 HCT 116 C39(1.59)  LDD0686  [8]
 LDCM0370  CL101 PaTu 8988t C39(0.65)  LDD1249  [8]
 LDCM0371  CL102 PaTu 8988t C39(0.61)  LDD1250  [8]
 LDCM0372  CL103 PaTu 8988t C39(0.24)  LDD1251  [8]
 LDCM0373  CL104 PaTu 8988t C39(0.56)  LDD1252  [8]
 LDCM0374  CL105 HCT 116 C39(0.63); C162(1.10)  LDD0691  [8]
 LDCM0375  CL106 HCT 116 C39(0.19); C162(0.92)  LDD0692  [8]
 LDCM0376  CL107 HCT 116 C39(0.35); C162(1.08)  LDD0693  [8]
 LDCM0377  CL108 HCT 116 C39(0.29); C162(1.13)  LDD0694  [8]
 LDCM0378  CL109 HCT 116 C39(0.73); C162(0.92)  LDD0695  [8]
 LDCM0379  CL11 HEK-293T C162(0.88)  LDD1583  [20]
 LDCM0380  CL110 HCT 116 C39(0.44); C162(0.92)  LDD0697  [8]
 LDCM0381  CL111 HCT 116 C39(0.80); C162(1.00)  LDD0698  [8]
 LDCM0382  CL112 HCT 116 C162(0.93); C39(0.94)  LDD0699  [8]
 LDCM0383  CL113 HCT 116 C39(0.48); C162(0.71)  LDD0700  [8]
 LDCM0384  CL114 HCT 116 C39(0.51); C162(0.58)  LDD0701  [8]
 LDCM0385  CL115 HCT 116 C39(0.68); C162(0.77)  LDD0702  [8]
 LDCM0386  CL116 HCT 116 C162(0.75); C39(0.89)  LDD0703  [8]
 LDCM0387  CL117 HCT 116 C162(0.86); C39(0.86)  LDD0704  [8]
 LDCM0388  CL118 HCT 116 C39(0.83); C162(1.31)  LDD0705  [8]
 LDCM0389  CL119 HCT 116 C39(0.91); C162(1.49)  LDD0706  [8]
 LDCM0390  CL12 HEK-293T C162(1.01)  LDD1594  [20]
 LDCM0391  CL120 HCT 116 C39(0.84); C162(1.53)  LDD0708  [8]
 LDCM0392  CL121 HCT 116 C39(1.09)  LDD0709  [8]
 LDCM0393  CL122 HCT 116 C39(1.01)  LDD0710  [8]
 LDCM0394  CL123 HCT 116 C39(0.98)  LDD0711  [8]
 LDCM0395  CL124 HCT 116 C39(1.03)  LDD0712  [8]
 LDCM0396  CL125 HCT 116 C39(0.82); C162(1.31)  LDD0713  [8]
 LDCM0397  CL126 HCT 116 C162(1.16); C39(1.50)  LDD0714  [8]
 LDCM0398  CL127 HCT 116 C39(0.46); C162(1.36)  LDD0715  [8]
 LDCM0399  CL128 HCT 116 C39(0.24); C162(0.98)  LDD0716  [8]
 LDCM0400  CL13 HEK-293T C162(1.06)  LDD1604  [20]
 LDCM0401  CL14 HEK-293T C162(1.17)  LDD1605  [20]
 LDCM0402  CL15 HEK-293T C162(1.12); C39(1.10)  LDD1606  [20]
 LDCM0403  CL16 HCT 116 C39(0.51)  LDD0720  [8]
 LDCM0404  CL17 HCT 116 C39(0.37)  LDD0721  [8]
 LDCM0405  CL18 HCT 116 C39(0.17)  LDD0722  [8]
 LDCM0406  CL19 HCT 116 C39(0.28)  LDD0723  [8]
 LDCM0407  CL2 HEK-293T C162(1.08)  LDD1611  [20]
 LDCM0408  CL20 HCT 116 C39(0.24)  LDD0725  [8]
 LDCM0409  CL21 HCT 116 C39(0.15)  LDD0726  [8]
 LDCM0410  CL22 HCT 116 C39(0.11)  LDD0727  [8]
 LDCM0411  CL23 HCT 116 C39(0.40)  LDD0728  [8]
 LDCM0412  CL24 HCT 116 C39(0.13)  LDD0729  [8]
 LDCM0413  CL25 HCT 116 C39(0.18)  LDD0730  [8]
 LDCM0414  CL26 HCT 116 C39(0.34)  LDD0731  [8]
 LDCM0415  CL27 HCT 116 C39(0.44)  LDD0732  [8]
 LDCM0416  CL28 HCT 116 C39(0.26)  LDD0733  [8]
 LDCM0417  CL29 HCT 116 C39(0.23)  LDD0734  [8]
 LDCM0418  CL3 HEK-293T C162(1.11); C39(1.06)  LDD1622  [20]
 LDCM0419  CL30 HCT 116 C39(0.36)  LDD0736  [8]
 LDCM0420  CL31 HCT 116 C39(0.64)  LDD0737  [8]
 LDCM0421  CL32 HCT 116 C39(0.34)  LDD0738  [8]
 LDCM0422  CL33 HCT 116 C39(0.40)  LDD0739  [8]
 LDCM0423  CL34 HCT 116 C39(0.23)  LDD0740  [8]
 LDCM0424  CL35 HCT 116 C39(0.25)  LDD0741  [8]
 LDCM0425  CL36 HCT 116 C39(0.32)  LDD0742  [8]
 LDCM0426  CL37 HCT 116 C39(0.22)  LDD0743  [8]
 LDCM0428  CL39 HCT 116 C39(0.25)  LDD0745  [8]
 LDCM0429  CL4 HEK-293T C162(0.90); C39(1.23)  LDD1633  [20]
 LDCM0430  CL40 HCT 116 C39(0.37)  LDD0747  [8]
 LDCM0431  CL41 HCT 116 C39(0.41)  LDD0748  [8]
 LDCM0432  CL42 HCT 116 C39(0.15)  LDD0749  [8]
 LDCM0433  CL43 HCT 116 C39(0.19)  LDD0750  [8]
 LDCM0434  CL44 HCT 116 C39(0.27)  LDD0751  [8]
 LDCM0435  CL45 HCT 116 C39(0.19)  LDD0752  [8]
 LDCM0436  CL46 HCT 116 C162(1.46)  LDD0753  [8]
 LDCM0437  CL47 HCT 116 C162(1.55)  LDD0754  [8]
 LDCM0438  CL48 HCT 116 C162(1.39)  LDD0755  [8]
 LDCM0439  CL49 HCT 116 C162(1.49)  LDD0756  [8]
 LDCM0440  CL5 HEK-293T C162(0.99)  LDD1644  [20]
 LDCM0441  CL50 HCT 116 C162(1.18)  LDD0758  [8]
 LDCM0442  CL51 HCT 116 C162(1.32)  LDD0759  [8]
 LDCM0443  CL52 HCT 116 C162(1.32)  LDD0760  [8]
 LDCM0444  CL53 HCT 116 C162(0.74)  LDD0761  [8]
 LDCM0445  CL54 HCT 116 C162(1.12)  LDD0762  [8]
 LDCM0446  CL55 HCT 116 C162(0.93)  LDD0763  [8]
 LDCM0447  CL56 HCT 116 C162(1.04)  LDD0764  [8]
 LDCM0448  CL57 HCT 116 C162(0.95)  LDD0765  [8]
 LDCM0449  CL58 HCT 116 C162(1.39)  LDD0766  [8]
 LDCM0450  CL59 HCT 116 C162(1.09)  LDD0767  [8]
 LDCM0451  CL6 HEK-293T C162(1.13)  LDD1654  [20]
 LDCM0452  CL60 HCT 116 C162(1.52)  LDD0769  [8]
 LDCM0453  CL61 HCT 116 C162(1.07)  LDD0770  [8]
 LDCM0454  CL62 HCT 116 C162(1.37)  LDD0771  [8]
 LDCM0455  CL63 HCT 116 C162(0.87)  LDD0772  [8]
 LDCM0456  CL64 HCT 116 C162(1.10)  LDD0773  [8]
 LDCM0457  CL65 HCT 116 C162(0.98)  LDD0774  [8]
 LDCM0458  CL66 HCT 116 C162(1.18)  LDD0775  [8]
 LDCM0459  CL67 HCT 116 C162(0.87)  LDD0776  [8]
 LDCM0460  CL68 HCT 116 C162(0.71)  LDD0777  [8]
 LDCM0461  CL69 HCT 116 C162(0.83)  LDD0778  [8]
 LDCM0462  CL7 HEK-293T C162(1.21)  LDD1665  [20]
 LDCM0463  CL70 HCT 116 C162(0.77)  LDD0780  [8]
 LDCM0464  CL71 HCT 116 C162(0.78)  LDD0781  [8]
 LDCM0465  CL72 HCT 116 C162(0.85)  LDD0782  [8]
 LDCM0466  CL73 HCT 116 C162(0.90)  LDD0783  [8]
 LDCM0467  CL74 HCT 116 C162(0.80)  LDD0784  [8]
 LDCM0469  CL76 HCT 116 C162(0.71); C39(0.39)  LDD0786  [8]
 LDCM0470  CL77 HCT 116 C162(0.67); C39(0.66)  LDD0787  [8]
 LDCM0471  CL78 HCT 116 C162(0.74); C39(0.64)  LDD0788  [8]
 LDCM0472  CL79 HCT 116 C162(0.84); C39(0.27)  LDD0789  [8]
 LDCM0473  CL8 HEK-293T C162(1.31); C39(0.99)  LDD1676  [20]
 LDCM0474  CL80 HCT 116 C162(0.84); C39(0.40)  LDD0791  [8]
 LDCM0475  CL81 HCT 116 C162(0.98); C39(0.45)  LDD0792  [8]
 LDCM0476  CL82 HCT 116 C162(1.04); C39(0.14)  LDD0793  [8]
 LDCM0477  CL83 HCT 116 C162(0.74); C39(0.18)  LDD0794  [8]
 LDCM0478  CL84 HCT 116 C162(0.78); C39(0.13)  LDD0795  [8]
 LDCM0479  CL85 HCT 116 C162(0.65); C39(0.66)  LDD0796  [8]
 LDCM0480  CL86 HCT 116 C162(0.67); C39(0.99)  LDD0797  [8]
 LDCM0481  CL87 HCT 116 C162(0.75); C39(0.49)  LDD0798  [8]
 LDCM0482  CL88 HCT 116 C162(0.64); C39(0.20)  LDD0799  [8]
 LDCM0483  CL89 HCT 116 C162(0.76); C39(0.13)  LDD0800  [8]
 LDCM0484  CL9 HEK-293T C162(0.90)  LDD1687  [20]
 LDCM0485  CL90 HCT 116 C162(0.64); C39(0.85)  LDD0802  [8]
 LDCM0486  CL91 HCT 116 C39(0.80)  LDD0803  [8]
 LDCM0487  CL92 HCT 116 C39(0.89)  LDD0804  [8]
 LDCM0488  CL93 HCT 116 C39(1.32)  LDD0805  [8]
 LDCM0489  CL94 HCT 116 C39(1.52)  LDD0806  [8]
 LDCM0490  CL95 HCT 116 C39(0.90)  LDD0807  [8]
 LDCM0491  CL96 HCT 116 C39(0.88)  LDD0808  [8]
 LDCM0492  CL97 HCT 116 C39(0.89)  LDD0809  [8]
 LDCM0493  CL98 HCT 116 C39(1.27)  LDD0810  [8]
 LDCM0494  CL99 HCT 116 C39(1.39)  LDD0811  [8]
 LDCM0097  Dasatinib K562 17.07  LDD0270  [4]
 LDCM0495  E2913 HEK-293T C162(1.01); C39(1.00)  LDD1698  [20]
 LDCM0625  F8 Ramos C162(1.09)  LDD2187  [21]
 LDCM0572  Fragment10 Ramos C162(0.89)  LDD2189  [21]
 LDCM0573  Fragment11 Ramos C162(0.29)  LDD2190  [21]
 LDCM0574  Fragment12 Ramos C162(1.27)  LDD2191  [21]
 LDCM0575  Fragment13 Ramos C162(1.19)  LDD2192  [21]
 LDCM0576  Fragment14 Ramos C162(1.17)  LDD2193  [21]
 LDCM0579  Fragment20 Ramos C162(1.33)  LDD2194  [21]
 LDCM0580  Fragment21 Ramos C162(0.81)  LDD2195  [21]
 LDCM0582  Fragment23 Ramos C162(0.55)  LDD2196  [21]
 LDCM0578  Fragment27 Ramos C162(0.73)  LDD2197  [21]
 LDCM0586  Fragment28 Ramos C162(1.67)  LDD2198  [21]
 LDCM0588  Fragment30 Ramos C162(1.03)  LDD2199  [21]
 LDCM0589  Fragment31 Ramos C162(0.68)  LDD2200  [21]
 LDCM0590  Fragment32 Ramos C162(1.03)  LDD2201  [21]
 LDCM0468  Fragment33 HCT 116 C162(0.99)  LDD0785  [8]
 LDCM0596  Fragment38 Ramos C162(1.62)  LDD2203  [21]
 LDCM0566  Fragment4 Ramos C162(0.99)  LDD2184  [21]
 LDCM0427  Fragment51 HCT 116 C39(0.15)  LDD0744  [8]
 LDCM0610  Fragment52 Ramos C162(1.82)  LDD2204  [21]
 LDCM0614  Fragment56 Ramos C162(1.23)  LDD2205  [21]
 LDCM0569  Fragment7 Ramos C162(1.11)  LDD2186  [21]
 LDCM0571  Fragment9 Ramos C162(1.39)  LDD2188  [21]
 LDCM0022  KB02 HEK-293T C162(0.94)  LDD1492  [20]
 LDCM0023  KB03 HEK-293T C162(1.00)  LDD1497  [20]
 LDCM0024  KB05 COLO792 C39(1.73)  LDD3310  [22]
 LDCM0514  Nucleophilic fragment 20a MDA-MB-231 C162(1.53)  LDD2107  [5]
 LDCM0534  Nucleophilic fragment 30a MDA-MB-231 C162(1.29)  LDD2127  [5]
 LDCM0549  Nucleophilic fragment 43 MDA-MB-231 C162(0.86)  LDD2143  [5]
 LDCM0550  Nucleophilic fragment 5a MDA-MB-231 C162(2.24)  LDD2144  [5]
 LDCM0553  Nucleophilic fragment 6b MDA-MB-231 C162(1.90)  LDD2147  [5]
 LDCM0628  OTUB2-COV-1 HEK-293T C119(2.17)  LDD2207  [23]

The Interaction Atlas With This Target

The Protein(s) Related To This Target

Enzyme
Click To Hide/Show 14 Protein(s) Interacting with This Target
Protein name Family Uniprot ID
Protein phosphatase 1A (PPM1A) PP2C family P35813
Ribosomal protein S6 kinase alpha-4 (RPS6KA4) AGC Ser/Thr protein kinase family O75676
MAP kinase-activated protein kinase 2 (MAPKAPK2) CAMK Ser/Thr protein kinase family P49137
MAP kinase-activated protein kinase 3 (MAPKAPK3) CAMK Ser/Thr protein kinase family Q16644
MAP kinase-interacting serine/threonine-protein kinase 1 (MKNK1) CAMK Ser/Thr protein kinase family Q9BUB5
MAP kinase-interacting serine/threonine-protein kinase 2 (MKNK2) CAMK Ser/Thr protein kinase family Q9HBH9
Mitogen-activated protein kinase 1 (MAPK1) CMGC Ser/Thr protein kinase family P28482
Mitogen-activated protein kinase 3 (MAPK3) CMGC Ser/Thr protein kinase family P27361
Dual specificity mitogen-activated protein kinase kinase 3 (MAP2K3) STE Ser/Thr protein kinase family P46734
Dual specificity mitogen-activated protein kinase kinase 6 (MAP2K6) STE Ser/Thr protein kinase family P52564
Dual specificity protein phosphatase 1 (DUSP1) Protein-tyrosine phosphatase family P28562
Dual specificity protein phosphatase 9 (DUSP9) Protein-tyrosine phosphatase family Q99956
Receptor-type tyrosine-protein phosphatase R (PTPRR) Protein-tyrosine phosphatase family Q15256
Elongation factor 1-alpha 1 (EEF1A1) Classic translation factor GTPase family P68104
Transporter and channel
Click To Hide/Show 1 Protein(s) Interacting with This Target
Protein name Family Uniprot ID
Nuclear pore complex protein Nup153 (NUP153) NUP153 family P49790
Other
Click To Hide/Show 5 Protein(s) Interacting with This Target
Protein name Family Uniprot ID
Retinoblastoma-associated protein (RB1) Retinoblastoma protein (RB) family P06400
Transcription factor SPT20 homolog (SUPT20H) SPT20 family Q8NEM7
Zinc finger HIT domain-containing protein 1 (ZNHIT1) ZNHIT1 family O43257
Hamartin (TSC1) . Q92574
mRNA decay activator protein ZFP36L1 (ZFP36L1) . Q07352

The Drug(s) Related To This Target

Approved
Click To Hide/Show 3 Drug(s) Interacting with This Target
Drug Name Drug Type External ID
Dasatinib Small molecular drug DB01254
Fostamatinib Small molecular drug DB12010
Minocycline Small molecular drug DB01017
Phase 4
Click To Hide/Show 1 Drug(s) Interacting with This Target
Drug Name Drug Type External ID
Ozagrel Small molecular drug D0C7AA
Phase 3
Click To Hide/Show 1 Drug(s) Interacting with This Target
Drug Name Drug Type External ID
Losmapimod Small molecular drug D0C8DD
Phase 2
Click To Hide/Show 3 Drug(s) Interacting with This Target
Drug Name Drug Type External ID
Dilmapimod Small molecular drug D0K0JQ
Vx-702 Small molecular drug D0D9AH
Vx-745 Small molecular drug D02NNV
Investigative
Click To Hide/Show 101 Drug(s) Interacting with This Target
Drug Name Drug Type External ID
(5-amino-1-phenyl-1h-pyrazol-4-yl)Phenylmethanone Small molecular drug D08WFC
2-chlorophenol Small molecular drug D09ZZI
3-(1-naphthylmethoxy)Pyridin-2-amine Small molecular drug D09GQO
3-(Benzyloxy)Pyridin-2-amine Small molecular drug D09DRF
4,5,6,7-tetrabromo-1h-benzo[D][1,2,3]Triazole Small molecular drug D0O1YH
4-(2-ethyl-4-m-tolyl-thiazol-5-yl)-pyridine Small molecular drug D0S9SX
4-(4-fluorophenyl)-1-cycloropropylmethyl-5-(4-pyridyl)-imidazole Small molecular drug DB08522
4-(Fluorophenyl)-1-cyclopropylmethyl-5-(2-amino-4-pyrimidinyl)Imidazole Small molecular drug DB03980
4-phenoxy-n-(Pyridin-2-ylmethyl)Benzamide Small molecular drug D0QS9T
4-phenylsulfanyl-7h-pyrrolo[2,3-d]Pyrimidine Small molecular drug D0M3CT
4-[(3,5-diamino-1h-pyrazol-4-yl)Diazenyl]Phenol Small molecular drug D0A5RM
4-[3-(4-fluorophenyl)-1h-pyrazol-4-yl]Pyridine Small molecular drug DB07829
6-(4-fluoro-phenylsulfanyl)-9h-purine Small molecular drug D0Q8HM
6-benzylsulfanyl-9h-purine Small molecular drug D0BH7S
6-o-tolylquinazolin-2-amine Small molecular drug D09HXU
6-phenylsulfanyl-9h-purine Small molecular drug D04CRB
9-(4-fluoro-benzyl)-6-phenylsulfanyl-9h-purine Small molecular drug D0L3DF
9-benzyl-6-(4-fluoro-phenylsulfanyl)-9h-purine Small molecular drug D03XYK
9-benzyl-6-phenylsulfanyl-9h-purine Small molecular drug D00ODN
B-octylglucoside Small molecular drug D02UVH
Bisindolylmaleimide-i Small molecular drug D0TO6S
Ci-1040 Small molecular drug D0B9BU
Dihydro-quinolinone Small molecular drug D08BIP
Doramapimod Small molecular drug DB03044
Gw-788388 Small molecular drug D0C3AD
In-1130 Small molecular drug D0K6YK
In-1166 Small molecular drug D0H6ZP
Inhibitor Of P38 Kinase Small molecular drug DB01953
Kn-62 Small molecular drug D0N6ES
Kt-5720 Small molecular drug D0G2VC
L-779450 Small molecular drug D06WJA
Ml-3163 Small molecular drug D08DSJ
Ml-3375 Small molecular drug D09HBZ
Ml-3403 Small molecular drug D0W4FF
N-(3-(Trifluoromethoxy)Benzyl)-4-phenoxybenzamide Small molecular drug D0N9HX
N-(3-(Trifluoromethyl)Benzyl)-4-phenoxybenzamide Small molecular drug D00PPB
N-(4-(Trifluoromethyl)Benzyl)-4-phenoxybenzamide Small molecular drug D0H8RU
N-(4-fluorobenzyl)-n-(Pyridin-4-yl)-2-naphthamide Small molecular drug D07TTR
N-(4-methyl-benzyl)-4-phenoxy-benzamide Small molecular drug D09XVY
Neflamapimod Small molecular drug DB07138
Oxindole 94 Small molecular drug D0VC0I
Pd-0166326 Small molecular drug D0P3JW
Pd-0173956 Small molecular drug D0GW4Q
Phenyl-(3-phenyl-1h-indazol-6-yl)-amine Small molecular drug D0H2PE
Pmid22521646c12 Small molecular drug D09OKU
Ro-316233 Small molecular drug D0L8HO
Ro-3201195 Small molecular drug D0S6GE
Ro31-8220 Small molecular drug D0M5FF
Rwj-68354 Small molecular drug D06NUL
Sb-216995 Small molecular drug D0E4LU
Sb-218655 Small molecular drug D02NKV
Sb-227931 Small molecular drug D0M2OL
Small Molecule 34 Small molecular drug D01CRK
Talmapimod Small molecular drug D04HWF
Triazolopyridine Small molecular drug D0X5CM
Tyrphostin Ag-1478 Small molecular drug D0ZH1U
Zm-336372 Small molecular drug D00NWF
[5-amino-1-(4-fluorophenyl)-1h-pyrazol-4-yl](3-{[(2r)-23-dihydroxypropyl]Oxy}Phenyl)Methanone Small molecular drug DB08424
1-(26-dichlorophenyl)-5-(24-difluorophenyl)-7-piperazin-1-yl-34-dihydroquinazolin-2(1h)-one . DB02873
1-(26-dichlorophenyl)-5-(24-difluorophenyl)-7-piperidin-4-yl-34-dihydroquinolin-2(1h)-one . DB01948
1-(5-tert-butyl-2-methyl-2h-pyrazol-3-yl)-3-(4-chloro-phenyl)-urea . DB02277
1-[1-(3-aminophenyl)-3-tert-butyl-1h-pyrazol-5-yl]-3-naphthalen-1-ylurea . DB06882
2-(26-difluorophenoxy)-n-(2-fluorophenyl)-9-isopropyl-9h-purin-8-amine . DB08097
2-(Ethoxymethyl)-4-(4-fluorophenyl)-3-[2-(2-hydroxyphenoxy)Pyrimidin-4-yl]Isoxazol-5(2h)-one . DB08395
2-fluoro-4-[4-(4-fluorophenyl)-1h-pyrazol-3-yl]Pyridine . DB07942
3-(2-chlorophenyl)-1-(2-{[(1s)-2-hydroxy-12-dimethylpropyl]Amino}Pyrimidin-4-yl)-1-(4-methoxyphenyl)Urea . DB08095
3-(4-fluorophenyl)-1-hydroxy-2-(Pyridin-4-yl)-1h-pyrrolo[32-b]Pyridine . DB02195
3-fluoro-5-morpholin-4-yl-n-[1-(2-pyridin-4-ylethyl)-1h-indol-6-yl]Benzamide . DB08730
3-fluoro-5-morpholin-4-yl-n-[3-(2-pyridin-4-ylethyl)-1h-indol-5-yl]Benzamide . DB08091
3-fluoro-n-1h-indol-5-yl-5-morpholin-4-ylbenzamide . DB08092
4-(2-hydroxybenzylamino)-n-(3-(4-fluorophenoxy)Phenyl)Piperidine-1-sulfonamide . DB04632
4-[3-methylsulfanylanilino]-67-dimethoxyquinazoline . DB02984
4-[4-(4-fluorophenyl)-2-[4-[(R)-methylsulfinyl]Phenyl]-1h-imidazol-5-yl]Pyridine . DB08521
4-[5-(3-iodo-phenyl)-2-(4-methanesulfinyl-phenyl)-1h-imidazol-4-yl]-pyridine . DB07607
4-[5-[2-(1-phenyl-ethylamino)-pyrimidin-4-yl]-1-methyl-4-(3-trifluoromethylphenyl)-1h-imidazol-2-yl]-piperidine . DB01761
4-{4-[(5-hydroxy-2-methylphenyl)Amino]Quinolin-7-yl}-13-thiazole-2-carbaldehyde . DB07832
6((S)-3-benzylpiperazin-1-yl)-3-(Naphthalen-2-yl)-4-(Pyridin-4-yl)Pyrazine . DB01988
6-[4-(2-fluorophenyl)-13-oxazol-5-yl]-n-(1-methylethyl)-13-benzothiazol-2-amine . DB08352
8-(2-chlorophenylamino)-2-(26-difluorophenylamino)-9-ethyl-9h-purine-17-diium . DB08096
Dp-802 . D0S4BP
Gsk-280 . D0DK2X
Kc706 . DB05157
N-(3-cyanophenyl)-2'-methyl-5'-(5-methyl-134-oxadiazol-2-yl)-4-biphenylcarboxamide . DB07833
N-(3-tert-butyl-1h-pyrazol-5-yl)-n'-{4-chloro-3-[(Pyridin-3-yloxy)Methyl]Phenyl}Urea . DB08064
N-(Cyclopropylmethyl)-2'-methyl-5'-(5-methyl-134-oxadiazol-2-yl)Biphenyl-4-carboxamide . DB07834
N-cyclopropyl-2'6-dimethyl-4'-(5-methyl-134-oxadiazol-2-yl)Biphenyl-3-carboxamide . DB07811
N-cyclopropyl-3-{[1-(24-difluorophenyl)-7-methyl-6-oxo-67-dihydro-1h-pyrazolo[34-b]Pyridin-4-yl]Amino}-4-methylbenzamide . DB08349
N-cyclopropyl-4-methyl-3-[1-(2-methylphenyl)Phthalazin-6-yl]Benzamide . DB07307
N-cyclopropyl-4-methyl-3-{2-[(2-morpholin-4-ylethyl)Amino]Quinazolin-6-yl}Benzamide . DB08351
N-ethyl-4-{[5-(Methoxycarbamoyl)-2-methylphenyl]Amino}-5-methylpyrrolo[21-f][124]Triazine-6-carboxamide . DB06940
N-[(3z)-5-tert-butyl-2-phenyl-12-dihydro-3h-pyrazol-3-ylidene]-n'-(4-chlorophenyl)Urea . DB01807
N-[2-methyl-5-(Methylcarbamoyl)Phenyl]-2-{[(1r)-1-methylpropyl]Amino}-13-thiazole-5-carboxamide . DB06991
N-[4-chloro-3-(Pyridin-3-yloxymethyl)-phenyl]-3-fluoro- . DB08068
N4-dimethyl-3-[(1-phenyl-1h-pyrazolo[34-d]Pyrimidin-4-yl)Amino]Benzamide . DB08242
N~3~-cyclopropyl-n~4~'-(Cyclopropylmethyl)-6-methylbiphenyl-34'-dicarboxamide . DB07835
Ph-797804 . DB07941
Pha-666859 . D0L1NU
Sd-0006 . DB07943
Staurosporinone . D0GB4V
Ucb-1277763 . D00YRF
[5-amino-1-(4-fluorophenyl)-1h-pyrazol-4-yl][3-(Piperidin-4-yloxy)Phenyl]Methanone . DB08423
Patented
Click To Hide/Show 6 Drug(s) Interacting with This Target
Drug Name Drug Type External ID
Pmid25991433-compound-o2 Peptide D03JFK
Pmid25991433-compound-a1 Small molecular drug D0H4HD
Pmid25991433-compound-f2 Small molecular drug D06JRV
Pmid25991433-compound-l1 Small molecular drug D0Q8CR
Pmid25991433-compound-l2 Small molecular drug D08OJQ
Pmid25991433-compound-l3 Small molecular drug D0G7LB
Discontinued
Click To Hide/Show 8 Drug(s) Interacting with This Target
Drug Name Drug Type External ID
Fr167653 Small molecular drug D05QMG
Pamapimod Small molecular drug D04WCI
R-1487 Small molecular drug D04YHW
Sb 203580 Small molecular drug D0F8DL
Sb 235699 Small molecular drug D0W0AM
Sb-242235 Small molecular drug D0A9KI
Sb220025 Small molecular drug D09ICC
Sc-102 Small molecular drug D0O7BW

References

1 Chemoproteomic profiling of kinases in live cells using electrophilic sulfonyl triazole probes. Chem Sci. 2021 Jan 21;12(9):3295-3307. doi: 10.1039/d0sc06623k.
2 A Paal-Knorr agent for chemoproteomic profiling of targets of isoketals in cells. Chem Sci. 2021 Oct 15;12(43):14557-14563. doi: 10.1039/d1sc02230j. eCollection 2021 Nov 10.
Mass spectrometry data entry: PXD028270
3 Quantitative and Site-Specific Chemoproteomic Profiling of Targets of Acrolein. Chem Res Toxicol. 2019 Mar 18;32(3):467-473. doi: 10.1021/acs.chemrestox.8b00343. Epub 2019 Jan 15.
4 Streamlined Target Deconvolution Approach Utilizing a Single Photoreactive Chloroalkane Capture Tag. ACS Chem Biol. 2021 Feb 19;16(2):404-413. doi: 10.1021/acschembio.0c00987. Epub 2021 Feb 5.
5 Nucleophilic covalent ligand discovery for the cysteine redoxome. Nat Chem Biol. 2023 Nov;19(11):1309-1319. doi: 10.1038/s41589-023-01330-5. Epub 2023 May 29.
Mass spectrometry data entry: PXD039908 , PXD029761
6 Chemoproteomic capture of RNA binding activity in living cells. Nat Commun. 2023 Oct 7;14(1):6282. doi: 10.1038/s41467-023-41844-z.
Mass spectrometry data entry: PXD044625
7 Global targeting of functional tyrosines using sulfur-triazole exchange chemistry. Nat Chem Biol. 2020 Feb;16(2):150-159. doi: 10.1038/s41589-019-0404-5. Epub 2019 Nov 25.
8 Reimagining high-throughput profiling of reactive cysteines for cell-based screening of large electrophile libraries. Nat Biotechnol. 2021 May;39(5):630-641. doi: 10.1038/s41587-020-00778-3. Epub 2021 Jan 4.
9 Targeted Proteomic Approaches for Proteome-Wide Characterizations of the AMP-Binding Capacities of Kinases. J Proteome Res. 2022 Aug 5;21(8):2063-2070. doi: 10.1021/acs.jproteome.2c00225. Epub 2022 Jul 12.
10 Enhancing Cysteine Chemoproteomic Coverage through Systematic Assessment of Click Chemistry Product Fragmentation. Anal Chem. 2022 Mar 8;94(9):3800-3810. doi: 10.1021/acs.analchem.1c04402. Epub 2022 Feb 23.
Mass spectrometry data entry: PXD028853
11 Chemoproteomic Profiling by Cysteine Fluoroalkylation Reveals Myrocin G as an Inhibitor of the Nonhomologous End Joining DNA Repair Pathway. J Am Chem Soc. 2021 Dec 8;143(48):20332-20342. doi: 10.1021/jacs.1c09724. Epub 2021 Nov 24.
Mass spectrometry data entry: PXD029255
12 Multiplexed CuAAC Suzuki-Miyaura Labeling for Tandem Activity-Based Chemoproteomic Profiling. Anal Chem. 2021 Feb 2;93(4):2610-2618. doi: 10.1021/acs.analchem.0c04726. Epub 2021 Jan 20.
Mass spectrometry data entry: PXD022279
13 Benchmarking Cleavable Biotin Tags for Peptide-Centric Chemoproteomics. J Proteome Res. 2022 May 6;21(5):1349-1358. doi: 10.1021/acs.jproteome.2c00174. Epub 2022 Apr 25.
Mass spectrometry data entry: PXD031019
14 Tunable Amine-Reactive Electrophiles for Selective Profiling of Lysine. Angew Chem Int Ed Engl. 2022 Jan 26;61(5):e202112107. doi: 10.1002/anie.202112107. Epub 2021 Dec 16.
15 ACR-Based Probe for the Quantitative Profiling of Histidine Reactivity in the Human Proteome. J Am Chem Soc. 2023 Mar 8;145(9):5252-5260. doi: 10.1021/jacs.2c12653. Epub 2023 Feb 27.
16 Chemoproteomic profiling of targets of lipid-derived electrophiles by bioorthogonal aminooxy probe. Redox Biol. 2017 Aug;12:712-718. doi: 10.1016/j.redox.2017.04.001. Epub 2017 Apr 5.
17 N-Acryloylindole-alkyne (NAIA) enables imaging and profiling new ligandable cysteines and oxidized thiols by chemoproteomics. Nat Commun. 2023 Jun 15;14(1):3564. doi: 10.1038/s41467-023-39268-w.
Mass spectrometry data entry: PXD041264
18 Large-scale chemoproteomics expedites ligand discovery and predicts ligand behavior in cells. Science. 2024 Apr 26;384(6694):eadk5864. doi: 10.1126/science.adk5864. Epub 2024 Apr 26.
Mass spectrometry data entry: PXD041587
19 Cell-based proteome profiling of potential dasatinib targets by use of affinity-based probes. J Am Chem Soc. 2012 Feb 15;134(6):3001-14. doi: 10.1021/ja208518u. Epub 2012 Feb 1.
20 Accelerating multiplexed profiling of protein-ligand interactions: High-throughput plate-based reactive cysteine profiling with minimal input. Cell Chem Biol. 2024 Mar 21;31(3):565-576.e4. doi: 10.1016/j.chembiol.2023.11.015. Epub 2023 Dec 19.
Mass spectrometry data entry: PXD044402
21 Site-specific quantitative cysteine profiling with data-independent acquisition-based mass spectrometry. Methods Enzymol. 2023;679:295-322. doi: 10.1016/bs.mie.2022.07.037. Epub 2022 Sep 7.
Mass spectrometry data entry: PXD027578
22 DrugMap: A quantitative pan-cancer analysis of cysteine ligandability. Cell. 2024 May 9;187(10):2536-2556.e30. doi: 10.1016/j.cell.2024.03.027. Epub 2024 Apr 22.
Mass spectrometry data entry: PXD047840
23 Rapid Covalent-Probe Discovery by Electrophile-Fragment Screening. J Am Chem Soc. 2019 Jun 5;141(22):8951-8968. doi: 10.1021/jacs.9b02822. Epub 2019 May 22.